invenens limited
invenens limited Company Information
Company Number
09192949
Next Accounts
Sep 2025
Shareholders
ausurus group ltd
Group Structure
View All
Industry
Activities of head offices
Registered Address
sirius house delta crescent, westbrook, warrington, WA5 7NS
Website
-invenens limited Estimated Valuation
Pomanda estimates the enterprise value of INVENENS LIMITED at £0 based on a Turnover of £0 and 0.5x industry multiple (adjusted for size and gross margin).
invenens limited Estimated Valuation
Pomanda estimates the enterprise value of INVENENS LIMITED at £0 based on an EBITDA of £-37.9m and a 3.81x industry multiple (adjusted for size and gross margin).
invenens limited Estimated Valuation
Pomanda estimates the enterprise value of INVENENS LIMITED at £0 based on Net Assets of £-39.1m and 2.14x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Invenens Limited Overview
Invenens Limited is a live company located in warrington, WA5 7NS with a Companies House number of 09192949. It operates in the activities of head offices sector, SIC Code 70100. Founded in August 2014, it's largest shareholder is ausurus group ltd with a 100% stake. Invenens Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Invenens Limited Health Check
There is insufficient data available to calculate a health check for Invenens Limited. Company Health Check FAQs
0 Strong
0 Regular
4 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Invenens Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (7.4%)
- - Invenens Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Invenens Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Invenens Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (110)
- Invenens Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Invenens Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Invenens Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Invenens Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Invenens Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Invenens Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (15 weeks)
- - Invenens Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 226.3%, this is a higher level of debt than the average (55.6%)
- - Invenens Limited
- - Industry AVG
INVENENS LIMITED financials
Invenens Limited's latest turnover from December 2023 is 0 and the company has net assets of -£39.1 million. According to their latest financial statements, we estimate that Invenens Limited has 1 employee and maintains cash reserves of £15 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | 32,000 | 42,000 | 15,000 | ||||||
| Other Income Or Grants | |||||||||
| Cost Of Sales | |||||||||
| Gross Profit | |||||||||
| Admin Expenses | |||||||||
| Operating Profit | -37,891,000 | -1,154,000 | -702,000 | -1,017,000 | -1,671,000 | -45,897,000 | -1,127,000 | -712,000 | -834,000 |
| Interest Payable | |||||||||
| Interest Receivable | 33,000 | ||||||||
| Pre-Tax Profit | -37,891,000 | -1,121,000 | -702,000 | -1,017,000 | -1,671,000 | -45,897,000 | -1,127,000 | -712,000 | -834,000 |
| Tax | -171,000 | 161,000 | 361,000 | 169,000 | |||||
| Profit After Tax | -37,891,000 | -1,121,000 | -702,000 | -1,017,000 | -1,842,000 | -45,736,000 | -766,000 | -712,000 | -665,000 |
| Dividends Paid | |||||||||
| Retained Profit | -37,891,000 | -1,121,000 | -702,000 | -1,017,000 | -1,842,000 | -45,736,000 | -766,000 | -712,000 | -665,000 |
| Employee Costs | |||||||||
| Number Of Employees | |||||||||
| EBITDA* | -37,891,000 | -1,154,000 | -702,000 | -1,017,000 | -1,671,000 | -45,897,000 | -1,127,000 | -712,000 | -834,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||
| Intangible Assets | |||||||||
| Investments & Other | 18,719,000 | 48,521,000 | 29,707,000 | 29,707,000 | 29,707,000 | 29,707,000 | 24,707,000 | 10,057,000 | |
| Debtors (Due After 1 year) | |||||||||
| Total Fixed Assets | 18,719,000 | 48,521,000 | 29,707,000 | 29,707,000 | 29,707,000 | 29,707,000 | 24,707,000 | 10,057,000 | |
| Stock & work in progress | |||||||||
| Trade Debtors | 19,000 | 15,000 | |||||||
| Group Debtors | 12,192,000 | 4,475,000 | 4,120,000 | 4,090,000 | 4,059,000 | 4,000,000 | 530,000 | ||
| Misc Debtors | 19,000 | 19,000 | 19,000 | 19,000 | 169,000 | 169,000 | |||
| Cash | 15,000 | 5,000 | |||||||
| misc current assets | |||||||||
| total current assets | 12,226,000 | 4,499,000 | 4,139,000 | 4,109,000 | 4,078,000 | 4,015,000 | 530,000 | 169,000 | 169,000 |
| total assets | 30,945,000 | 53,020,000 | 33,846,000 | 33,816,000 | 33,785,000 | 33,722,000 | 25,237,000 | 10,226,000 | 169,000 |
| Bank overdraft | |||||||||
| Bank loan | |||||||||
| Trade Creditors | 3,000 | ||||||||
| Group/Directors Accounts | 70,024,000 | 58,600,000 | 85,286,000 | 84,554,000 | 83,503,000 | 81,601,000 | 27,380,000 | 11,603,000 | 834,000 |
| other short term finances | |||||||||
| hp & lease commitments | |||||||||
| other current liabilities | |||||||||
| total current liabilities | 70,024,000 | 58,600,000 | 85,286,000 | 84,554,000 | 83,506,000 | 81,601,000 | 27,380,000 | 11,603,000 | 834,000 |
| loans | |||||||||
| hp & lease commitments | |||||||||
| Accruals and Deferred Income | |||||||||
| other liabilities | |||||||||
| provisions | |||||||||
| total long term liabilities | |||||||||
| total liabilities | 70,024,000 | 58,600,000 | 85,286,000 | 84,554,000 | 83,506,000 | 81,601,000 | 27,380,000 | 11,603,000 | 834,000 |
| net assets | -39,079,000 | -5,580,000 | -51,440,000 | -50,738,000 | -49,721,000 | -47,879,000 | -2,143,000 | -1,377,000 | -665,000 |
| total shareholders funds | -39,079,000 | -5,580,000 | -51,440,000 | -50,738,000 | -49,721,000 | -47,879,000 | -2,143,000 | -1,377,000 | -665,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | -37,891,000 | -1,154,000 | -702,000 | -1,017,000 | -1,671,000 | -45,897,000 | -1,127,000 | -712,000 | -834,000 |
| Depreciation | |||||||||
| Amortisation | |||||||||
| Tax | -171,000 | 161,000 | 361,000 | 169,000 | |||||
| Stock | |||||||||
| Debtors | 7,717,000 | 355,000 | 30,000 | 31,000 | 63,000 | 3,485,000 | 361,000 | 169,000 | |
| Creditors | -3,000 | 3,000 | |||||||
| Accruals and Deferred Income | |||||||||
| Deferred Taxes & Provisions | |||||||||
| Cash flow from operations | -45,608,000 | -1,509,000 | -732,000 | -1,051,000 | -1,902,000 | -49,221,000 | -1,127,000 | -712,000 | -834,000 |
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | -29,802,000 | 18,814,000 | 5,000,000 | 14,650,000 | 10,057,000 | ||||
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | |||||||||
| Group/Directors Accounts | 11,424,000 | -26,686,000 | 732,000 | 1,051,000 | 1,902,000 | 54,221,000 | 15,777,000 | 10,769,000 | 834,000 |
| Other Short Term Loans | |||||||||
| Long term loans | |||||||||
| Hire Purchase and Lease Commitments | |||||||||
| other long term liabilities | |||||||||
| share issue | |||||||||
| interest | 33,000 | ||||||||
| cash flow from financing | 15,816,000 | 20,328,000 | 732,000 | 1,051,000 | 1,902,000 | 54,221,000 | 15,777,000 | 10,769,000 | 834,000 |
| cash and cash equivalents | |||||||||
| cash | 10,000 | 5,000 | |||||||
| overdraft | |||||||||
| change in cash | 10,000 | 5,000 |
invenens limited Credit Report and Business Information
Invenens Limited Competitor Analysis
Perform a competitor analysis for invenens limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other established companies, companies in WA5 area or any other competitors across 12 key performance metrics.
invenens limited Ownership
INVENENS LIMITED group structure
Invenens Limited has 1 subsidiary company.
Ultimate parent company
1 parent
INVENENS LIMITED
09192949
1 subsidiary
invenens limited directors
Invenens Limited currently has 2 directors. The longest serving directors include Mr Neil Stinson (Aug 2014) and Mr Christopher Sheppard (Aug 2014).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Neil Stinson | United Kingdom | 54 years | Aug 2014 | - | Director |
| Mr Christopher Sheppard | England | 50 years | Aug 2014 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
-37.9m
+3183%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-39.1m
+6%
total assets
30.9m
-0.42%
cash
15k
+2%
net assets
Total assets minus all liabilities
invenens limited company details
company number
09192949
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
August 2014
age
11
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
KPMG LLP
address
sirius house delta crescent, westbrook, warrington, WA5 7NS
Bank
-
Legal Advisor
-
invenens limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to invenens limited.
invenens limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INVENENS LIMITED. This can take several minutes, an email will notify you when this has completed.
invenens limited Companies House Filings - See Documents
| date | description | view/download |
|---|
